Showing results (1721-1730 of 1,853) with videos related to
Sort By:
Pageof 186
Annals of Clinical and Translational Neurology|February 5, 2024
SPTLC2 variants are associated with early-onset ALS and FTD due to aberrant sphingolipid synthesisHiroya Naruse, Hiroyuki Ishiura, Kayoko Esaki, et al.Cancer Science|June 14, 2022
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancerKensei Yamaguchi, Keiko Minashi, Daisuke Sakai, et al.Journal of Gastroenterology|March 2, 2022
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluationMasahiro Kishi, Fumihito Hirai, Noritaka Takatsu, et al.Cancer Science|August 25, 2018
Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancerMichitaka Nakano, Mamoru Ito, Risa Tanaka, et al.Endoscopic Ultrasound|July 1, 2024
Diagnostic performance of EUS-guided tissue acquisition for solid pancreatic lesions ≤10 mmYuki Kawasaki, Susumu Hijioka, Yoshikuni Nagashio, et al.Surgical Endoscopy|February 27, 2019
Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysisOsamu Dohi, Waku Hatta, Takuji Gotoda, et al.Nature Communications|October 19, 2024
Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancerKenro Tanoue, Hirofumi Ohmura, Koki Uehara, et al.The New England Journal of Medicine|October 23, 2023
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12CMarwan G Fakih, Lisa Salvatore, Taito Esaki, et al.Journal of Gastroenterology|April 22, 2016
Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in JapanWaku Hatta, Takuji Gotoda, Tsuneo Oyama, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 30, 2015
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancerKohei Shitara, Kei Muro, Yasuhiro Shimada, et al.Pageof 186